Regression of choroidal metastasis from breast carcinoma following Letrozole therapy.
Metastasis to the choroid from primary tumours elsewhere in the body is not an infrequent occurrence. Management of such metastasis may involve modalities such as radiotherapy, chemotherapy, photocoagulation and surgical resection. The role of hormonal therapy is poorly defined in the management of these tumours. Herein regression of choroidal metastasis from primary breast carcinoma following antihormonal therapy with the antioestrogen drug Letrozole is reported.
Venkatesh
Pradeep
P
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Garg
Satpal
S
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000556:secondary; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D000077289:Letrozole; D009570:Nitriles / Q000627:therapeutic use*; D012074:Remission Induction; D041623:Tomography, Optical Coherence; D014230:Triazoles / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D020847:Estrogen Receptor Modulators; D009570:Nitriles; D014230:Triazoles; D000077289:Letrozole